180
Participants
Start Date
September 30, 2010
Primary Completion Date
December 31, 2011
Study Completion Date
December 31, 2011
Low Strength IDP-107
Once a day for 16 weeks
High Strength IDP-107
Once a day for 16 weeks
Placebo
Once a day for 16 weeks
Ameriderm Research, Ormond Beach
North Florida Dermatology Associates, PA, Jacksonville
FXM Research Corp., Miami
Pedia Research LLC, Owensboro
The Indiana Clinical Trials Center, PC, Plainfield
Dawes Fretzin Clinical Research Group, LLC, Indianapolis
Hamzavi Dermatology, Fort Gratiot
Minnesota Clinical Study Center, Fridley
DermResearch, Inc., Austin
Horizons Clinical Research Center, LLC, Denver
South Valley Dermatology, West Jordan
Dermatology Research Center, Inc., Salt Lake City
Dermatology Specialists, Inc., Oceanside
Oregon Dermatology and Research Center, Portland
Premier Clinical Research, Spokane
ActivMed Practices and Research, Inc., Haverhill
Comprehensive Clinical Research, Berlin
Ultranova Skincare, Barrie
The Centre for Dermatology and Cosmetic Surgery, Richmond Hill
K. Papp Clinical Research, Waterloo
Lead Sponsor
Dow Pharmaceutical Sciences
INDUSTRY